Annual CFO
-$27.36 M
+$3.71 M+11.96%
31 December 2023
Summary:
Tempest Therapeutics annual cash flow from operations is currently -$27.36 million, with the most recent change of +$3.71 million (+11.96%) on 31 December 2023. During the last 3 years, it has fallen by -$1.40 million (-5.39%). TPST annual CFO is now -43.86% below its all-time high of -$19.02 million, reached on 31 December 2020.TPST Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$10.18 M
-$4.67 M-84.79%
30 September 2024
Summary:
Tempest Therapeutics quarterly cash flow from operations is currently -$10.18 million, with the most recent change of -$4.67 million (-84.79%) on 30 September 2024. Over the past year, it has dropped by -$4.01 million (-64.89%). TPST quarterly CFO is now -8117.32% below its all-time high of $127.00 thousand, reached on 30 June 2021.TPST Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$29.05 M
-$3.69 M-14.57%
30 September 2024
Summary:
Tempest Therapeutics TTM cash flow from operations is currently -$29.05 million, with the most recent change of -$3.69 million (-14.57%) on 30 September 2024. Over the past year, it has dropped by -$1.70 million (-6.20%). TPST TTM CFO is now -369.89% below its all-time high of -$6.18 million, reached on 30 June 2021.TPST TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -64.9% | -6.2% |
| 3 y3 years | -5.4% | -27.5% | -11.9% |
| 5 y5 years | - | - | - |
TPST Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.4% | +12.0% | -84.8% | at low | -14.6% | +17.7% |
| 5 y | 5 years | -43.9% | +12.0% | -8117.3% | +13.6% | -369.9% | +17.7% |
| alltime | all time | -43.9% | +12.0% | -8117.3% | +13.6% | -369.9% | +17.7% |
Tempest Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.18 M(+84.8%) | -$29.05 M(+14.6%) |
| June 2024 | - | -$5.51 M(-23.3%) | -$25.36 M(-3.4%) |
| Mar 2024 | - | -$7.19 M(+16.4%) | -$26.24 M(-4.1%) |
| Dec 2023 | -$27.36 M(-12.0%) | -$6.17 M(-4.8%) | -$27.36 M(-1.1%) |
| Sept 2023 | - | -$6.49 M(+1.5%) | -$27.66 M(-8.5%) |
| June 2023 | - | -$6.39 M(-23.0%) | -$30.25 M(-6.3%) |
| Mar 2023 | - | -$8.30 M(+28.2%) | -$32.27 M(+3.8%) |
| Dec 2022 | -$31.07 M | -$6.48 M(-28.6%) | -$31.07 M(-4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$9.07 M(+7.8%) | -$32.58 M(-7.7%) |
| June 2022 | - | -$8.41 M(+18.4%) | -$35.30 M(+31.9%) |
| Mar 2022 | - | -$7.11 M(-11.0%) | -$26.75 M(+3.1%) |
| Dec 2021 | -$25.96 M(+36.5%) | -$7.99 M(-32.3%) | -$25.96 M(+44.4%) |
| Sept 2021 | - | -$11.79 M(-9382.7%) | -$17.97 M(+190.7%) |
| June 2021 | - | $127.00 K(-102.0%) | -$6.18 M(-2.0%) |
| Mar 2021 | - | -$6.31 M | -$6.31 M |
| Dec 2020 | -$19.02 M | - | - |
FAQ
- What is Tempest Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly CFO year-on-year change?
- What is Tempest Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Tempest Therapeutics?
- What is Tempest Therapeutics TTM CFO year-on-year change?
What is Tempest Therapeutics annual cash flow from operations?
The current annual CFO of TPST is -$27.36 M
What is the all time high annual CFO for Tempest Therapeutics?
Tempest Therapeutics all-time high annual cash flow from operations is -$19.02 M
What is Tempest Therapeutics quarterly cash flow from operations?
The current quarterly CFO of TPST is -$10.18 M
What is the all time high quarterly CFO for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly cash flow from operations is $127.00 K
What is Tempest Therapeutics quarterly CFO year-on-year change?
Over the past year, TPST quarterly cash flow from operations has changed by -$4.01 M (-64.89%)
What is Tempest Therapeutics TTM cash flow from operations?
The current TTM CFO of TPST is -$29.05 M
What is the all time high TTM CFO for Tempest Therapeutics?
Tempest Therapeutics all-time high TTM cash flow from operations is -$6.18 M
What is Tempest Therapeutics TTM CFO year-on-year change?
Over the past year, TPST TTM cash flow from operations has changed by -$1.70 M (-6.20%)